Cadila chairman Indravadan Modi passes away

Bangalore: Veteran industrialist and one of pioneers of Indian pharmaceuticals industry Mr Indravadan Modi, the chairman...

November 27, 2012 | Tuesday | News
First-of-its-kind osteoarthritis study done in India

Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoart...

September 21, 2012 | Friday | News
India to introduce new medical device Bill

Singapore: The Indian government will soon bring a Bill aimed at regulating the medical equipment industry in the county...

June 21, 2013 | Friday | Regulatory
Panacea gets govt order worth $34 million

New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order ...

December 17, 2012 | Monday | News
Indian FIPB clears pharma FDI proposals worth $536 mn

New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has...

August 27, 2012 | Monday | News
WHO: Invest in local research to improve healthcare

Singapore: WHO has urged countries to invest in local research in order to develop a system of universal health coverage...

August 19, 2013 | Monday | News
Arvind sets up $42.37 mn plant top tap US market

Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...

June 26, 2013 | Wednesday | News
BioEnable launch biometric kiosks

Bangalore: BioEnable Technologies announced the launch of their new generation Biometric Kiosks. The device type is use...

April 24, 2012 | Tuesday | News
What are India's most eminent life science individuals saying about CSIR?

India's Council of Scientific and Industrial Research (CSIR), which was established in 1942 as an autonomous society and...

November 21, 2012 | Wednesday | Analysis
Ranbaxy, Gilead sign licensing agreement

New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to hig...

August 3, 2012 | Friday | News
NSF brings Secondary Reference Standards to India

Singapore: NSF International, an independent global public health and safety organization which develops standards, and ...

April 24, 2012 | Tuesday | News
Abuse of clinical trial laws need to be prevented

Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, prop...

October 15, 2012 | Monday | Opinion
QIAGEN gets SFDA's nod for careHPV Test

Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test a...

April 24, 2012 | Tuesday | News
GlobalData: Osteoporosis market to be $8 bn

Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...

March 8, 2013 | Friday | Analysis
Cipla gets drug pricing breather from Delhi Court

Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not t...

July 31, 2013 | Wednesday | News
Industry body expresses concern over Nexavar decision

The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology i...

March 16, 2012 | Friday | News
APAC ovarian cancer drug market to grow modestly'

Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...

January 30, 2015 | Friday | Analysis
Hyderabad to host BioAsia from Jan 28

Bangalore: The 10th edition of much anticipated annual biotechnology and life sciences platform BioAsia will be held in ...

November 9, 2012 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls